deltatrials
Completed PHASE3 NCT03440814

A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

Sponsor: Soleno Therapeutics, Inc.

Conditions Prader-Willi Syndrome
Interventions DCCR Placebo for DCCR
Updated 24 times since 2018 Last updated: Aug 25, 2023 Started: May 9, 2018 Primary completion: May 1, 2020 Completion: May 1, 2020

This PHASE3 trial investigates Prader-Willi Syndrome and is currently completed. Soleno Therapeutics, Inc. leads this study, which shows 24 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

24 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jul 2022 — Oct 2023 [monthly]

    Completed PHASE3

  5. Jan 2021 — Jul 2022 [monthly]

    Completed PHASE3

▶ Show 19 earlier versions

  1. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  2. Feb 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  3. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE3

  4. Nov 2019 — Jan 2020 [monthly]

    Recruiting PHASE3

  5. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE3

  6. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  7. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

  8. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE3

  9. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  10. Apr 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

  11. Mar 2019 — Apr 2019 [monthly]

    Recruiting PHASE3

  12. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE3

  13. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE3

  14. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE3

  15. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE3

  16. Aug 2018 — Oct 2018 [monthly]

    Recruiting PHASE3

  17. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  18. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  19. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Soleno Therapeutics, Inc.
Data source: Soleno Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States, Aurora, United States, Bethesda, United States, Birmingham, United Kingdom, Boston, United States, Cambridge, United Kingdom, Cleveland, United States, Columbus, United States, Dallas, United States, Gainesville, United States and 16 more location s